Examkin

Question

Difficulty: HardGynecologic Infections

A 64-year-old woman, G3P3, presents to the outpatient clinic reporting a 2-week history of intense vulvovaginal itching, burning, and a malodorous, yellow-green vaginal discharge. During this time, she has also noticed intermittent, light vaginal bleeding. Her last menstrual period was 12 years ago. She recently became sexually active with a new male partner. Her past medical history includes hypertension and type 2 diabetes mellitus. Vital signs are within normal limits. Pelvic examination reveals a pale, thin vaginal mucosa with a loss of rugae. There is a copious, frothy, yellow-green discharge in the vaginal vault, and the cervix demonstrates punctate macular hemorrhages. A wet mount preparation of the discharge reveals abundant motile, flagellated, pear-shaped organisms and numerous polymorphonuclear leukocytes. Which of the following is the most appropriate next step in the management of this patient?

  1. Prescribe oral metronidazole and perform an endometrial biopsyAnswer
  2. B
    Prescribe oral metronidazole and schedule a follow-up visit to observe for resolution of the bleeding
  3. C
    Prescribe intramuscular ceftriaxone, oral doxycycline, and oral metronidazole, and perform an endometrial biopsy
  4. D
    Contact the patient's partner directly to provide concurrent treatment, and perform an endometrial biopsy
  5. E
    Prescribe intravaginal metronidazole cream and reassure the patient that the bleeding is secondary to vaginal atrophy

Answer

Prescribe oral metronidazole and perform an endometrial biopsy.
The correct answer addresses both of the patient's critical medical issues: acute trichomoniasis and postmenopausal bleeding. The wet mount showing motile, flagellated organisms confirms a Trichomonas vaginalis infection, which requires systemic therapy with oral metronidazole (topical therapies are ineffective because they do not reach the Skene's and Bartholin's glands). Furthermore, any vaginal bleeding in a postmenopausal woman must be considered a red flag for endometrial carcinoma until proven otherwise. Even when a plausible benign source of bleeding is identified—such as the friable, punctate cervical hemorrhages ('strawberry cervix') caused by trichomoniasis or her severe atrophic vaginitis—a tissue diagnosis via endometrial biopsy (or a transvaginal ultrasound showing an endometrial stripe ≤4\leq 4 mm) is mandatory to definitively rule out malignancy.

Step-by-Step Solution

1
Identify the etiology of the patient's vaginal discharge based on clinical and microscopic findings.
The diagnosis is Trichomonas vaginalis, indicated by the frothy yellow-green discharge, punctate cervical hemorrhages, and motile flagellated organisms on wet mount.
Establishing the infectious etiology is necessary to select the correct targeted antimicrobial therapy, which is systemic oral metronidazole.
2
Evaluate the significance of the patient's vaginal bleeding in the context of her age and menopausal status.
The bleeding must be classified as postmenopausal bleeding (PMB).
PMB is a classic presenting symptom of endometrial carcinoma and always requires immediate investigation.
3
Synthesize a comprehensive management plan for both clinical problems.
Prescribe oral metronidazole for the infection and simultaneously perform an endometrial biopsy to evaluate the bleeding.
Benign findings, such as an active infection or severe vaginal atrophy, do not eliminate the underlying risk of malignancy; concurrent thorough evaluation is the standard of care.

Key Concept

In postmenopausal women, any vaginal bleeding must be evaluated with an endometrial biopsy or transvaginal ultrasound to rule out endometrial carcinoma, regardless of the presence of concurrent benign pathologies that could also cause bleeding.
Estimated Time:1m 30s
Rate this question

Topics

Gynecologic Infections

More questions from this topic